[{"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; NAPROXEN, Tablet, 500 mg may be potentially mislabeled as    THIOTHIXENE, Capsule, 1 mg, NDC 00378100101, Pedigree: AD54549_22, EXP: 5/20/2014;  HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg, NDC 00228282011, Pedigree: AD67989_13, EXP: 5/28/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "NAPROXEN, Tablet, 500 mg has the following codes    Pedigree: AD54516_1, EXP: 5/20/2014;  Pedigree: AD68025_8, EXP: 5/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NAPROXEN, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 05374601901", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-495-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63285", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "200 Somerset Corporate Blvd Fl 7th", "address_2": "N/A", "postal_code": "08807-2862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-178-2013", "product_description": "Citalopram tablets USP, 10mg, 30-count bottle,  Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli,  India 502 325, NDC 55111-342-30", "product_quantity": "27,805 bottles", "reason_for_recall": "Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.", "recall_initiation_date": "20120801", "center_classification_date": "20130228", "termination_date": "20130524", "report_date": "20130306", "code_info": "Lot #: C201028, Exp 12/13"}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83137", "recalling_firm": "Amneal Pharmaceuticals, Inc.", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1439-2019", "product_description": "Esterified Estrogens & Methyltestosterone Tablets, USP  1.25 mg/2.5 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-172-01", "product_quantity": "19176 units", "reason_for_recall": "Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.", "recall_initiation_date": "20170925", "center_classification_date": "20190701", "termination_date": "20190808", "report_date": "20190710", "code_info": "Lot #: HL06015, HL06115, Exp. 10/2017"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "384", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Oxytocin 20 Units added to Lactated Ringers in a 1000 mL lntravia bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0769-04", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1299-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "72527", "recalling_firm": "Sanofi-Aventis U.S. LLC", "address_1": "55 Corporate Dr", "address_2": "N/A", "postal_code": "08807-1265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0873-2016", "product_description": "Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.15 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0024-5831-02) and (b) 1 prefilled auto injector + 1 trainer (NDC 0024-5831-00), Rx Only, Manufactured for Sanofi-Aventis US, LLC Bridgewater, NJ  08807 A Sanofi Company", "product_quantity": "159,000 prefilled injectors", "reason_for_recall": "Defective Delivery System; potential to have inaccurate dosage delivery", "recall_initiation_date": "20151028", "center_classification_date": "20160525", "termination_date": "20250715", "report_date": "20160601", "code_info": "a) 2144144, exp 10/2015;  2469674, exp 04/2016;  2506492, 2546978, 2546979, exp 05/2016;  2654817, 2654818, exp 06/2016;   2692143, 2692144, exp 07/2016;  2719838, exp 08/2016;  2824845, 2891021, 2857530, exp 09/2016;  2883631, 2883632, exp 10/2016;  2883633, 2945429, 3028243, exp 11/2016;  3037230, 2966680, 2974276, 2974280, exp 12/2016; and   b) 2525474, exp 05/2016"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0585-2022", "product_description": "Infant's Grape Flavored Acetaminophen Oral Suspension (160mg/5ml), 2 FL OZ (59 mL) per bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895.  NDC: 59779-946-16", "product_quantity": "37,152 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1CK1276, 1FK1184, 1GK0821 and 1EK1046, Exp 02/28/2023", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA060764"], "brand_name": ["NEO POLYCIN"], "generic_name": ["NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC"], "manufacturer_name": ["Padagis US LLC"], "product_ndc": ["0574-4250"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["BACITRACIN ZINC", "NEOMYCIN SULFATE", "POLYMYXIN B SULFATE"], "rxcui": ["308493", "1117090"], "spl_id": ["8482ca1e-d647-4e53-9326-218a0cd5bb18"], "spl_set_id": ["cf18b051-b656-4f46-8b69-a1df6f5d8d29"], "package_ndc": ["0574-4250-35"], "is_original_packager": [true], "unii": ["89Y4M234ES", "057Y626693", "19371312D4"]}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0353-2020", "product_description": "Perrigo Neo-Polycin neomycin and polymixin B sulfates and bacitracin zinc Ophthalmic Ointment Net Wt. 3.5 g, Rx only, Manufactured for Perrigo Minneapolis, MN 55427 NDC  0574-4250-35", "product_quantity": "121572 containers", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: SAC, Exp 1/20; SLK, Exp 12/20"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0421-2024", "product_description": "PHENYLephrine HCl 800 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 80mcg/mL) 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0816-12-K, Bar Code 700040081612. (same finished product as F078140, but with RFID for KitCheck compatibility)", "product_quantity": "2,427 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048610  Exp 04/10/24; 1223048611  Exp 04/10/24; 1223048726  Exp 04/13/24; 1223050163  Exp 06/12/24", "more_code_info": ""}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0353-2017", "product_description": "Dexamethasone Sodium Phosphate 200 mg/mL, Injectable, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "15 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 07082016@25."}, {"status": "Terminated", "city": "Polepally, Jadcherla", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86749", "recalling_firm": "Shilpa Medicare Limited", "address_1": "S-20 To S-26,  Pharm. Formulation Sez", "address_2": "Tsiic, Green Industrial Park", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0123-2021", "product_description": "Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotoxic Agent, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, NDC 72606-558-01.", "product_quantity": "6,560 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20201208", "center_classification_date": "20201209", "termination_date": "20220311", "report_date": "20201216", "code_info": "Lot #: 7S10227A, Exp. 10/31/2021"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; HYDROCHLOROTHIAZIDE Tablet, 12.5 mg may be potentially mislabeled as    chlordiazePOXIDE HCl, Capsule, 25 mg, NDC 00555015902, Pedigree: AD46333_4, EXP: 5/16/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "HYDROCHLOROTHIAZIDE Tablet, 12.5 mg has the following code    Pedigree: AD46414_25, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "HYDROCHLOROTHIAZIDE Tablet, 12.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16729018201", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-525-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 50 mg may have potentially been mislabeled as one of the following drugs:  ROSUVASTATIN CALCIUM, Tablet, 5 mg, NDC 00310075590, Pedigree: AD21811_10, EXP: 5/2/2014;  LIOTHYRONINE SODIUM, Tablet, 5 mcg, NDC 42794001802, Pedigree: AD46414_38, EXP: 5/16/2014.", "address_2": "", "product_quantity": "200 Capsules", "code_info": "NORTRIPTYLINE HCL, Capsule, 50 mg has the following codes:  Pedigree:  AD21790_70, EXP: 5/1/2014;  Pedigree:  AD46414_47, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NORTRIPTYLINE HCL, Capsule, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093081201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-828-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-829-2015", "product_description": "Paclitaxel Semi-Synthetic active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "10 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85547", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "1075 W Park One Dr Ste 100", "address_2": "N/A", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US.", "recall_number": "D-1335-2020", "product_description": "R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe, Compounded by QuVa 519 Bloombury, NJ 08804,  NDC 70092143350", "product_quantity": "17,050 syringes", "reason_for_recall": "Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac", "recall_initiation_date": "20200423", "center_classification_date": "20200623", "termination_date": "20210113", "report_date": "20200701", "code_info": "Lots: 30008721, Exp. 4/26/2020; 30008198, 30008554, Exp. 4/29/2020; 30008861, Exp. 4/30/2020; 30008859, Exp. 5/5/2020;  30008949, Exp. 5/10/2020; 30009073, Exp. 5/14/2020; 30009074, Exp. 30009138, Exp. 5/17/2020; 30009139, 30009227, Exp. 5/19/2020; 30009228, Exp. 5/20/2020; 30009387, 30009388, Exp. 5/27/2020; 30009410, 30009411, Exp. 5/28/2020; 30009413, Exp. 5/31/2020; 30009412,  30009489, Exp. 6/1/2020; 30009539, 30009563, Exp. 6/3/2020"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-501-2015", "product_description": "Acyclovir Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C245 BUD: 11/28/2018; D005 BUD: 1/5/2019; D027 BUD: 1/31/2019; D035 BUD: 2/9/2019; D058 BUD: 3/9/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Testosterone 37.5 mg pellet, 1 count (NDC 69761-137-01), 6 count (NDC 69761-137-06), 12 count (NDC 69761-137-12) and 30 count (NDC 69761-137-30) vials, Rx Only, Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0235-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "65840", "recalling_firm": "Novartis Consumer Health", "address_1": "10401 Hwy 6", "address_2": "N/A", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Canada, and Panama.", "recall_number": "D-910-2013", "product_description": "Maalox Nighttime Antacid with Acid Reflux Barrier (calcium carbonate and alginic acid) chewable tablets, 500 mg/200 mg, Cherry flavor, 65-count tablets per bottle, Novartis Consumer Health Canada Inc., Mississauga, ON L5N 2X7, foreign labeling containing English and French, NPN 80000899, UPC 0 58478 10090 6.", "product_quantity": "11,760 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.", "recall_initiation_date": "20130806", "center_classification_date": "20130820", "termination_date": "20141104", "report_date": "20130828", "code_info": "Lot #: 10114318, Exp 01/14"}, {"status": "Ongoing", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204821"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Solco Healthcare US, LLC"], "product_ndc": ["43547-367", "43547-368", "43547-369", "43547-370"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["c540c941-b8fc-4a32-bfa7-00fba4ca9dcf"], "spl_set_id": ["26080940-bcd3-446d-9026-3ddfb58e281e"], "package_ndc": ["43547-367-03", "43547-367-09", "43547-367-50", "43547-367-11", "43547-368-03", "43547-368-09", "43547-368-50", "43547-368-11", "43547-369-03", "43547-369-09", "43547-369-50", "43547-369-11", "43547-370-03", "43547-370-09", "43547-370-50", "43547-370-11"], "is_original_packager": [true], "upc": ["0343547370039", "0343547369033", "0343547368036", "0343547367039"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "80525", "recalling_firm": "Prinston Pharmaceutical Inc", "address_1": "2002 Eastpark Blvd", "address_2": "N/A", "postal_code": "08512-3514", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States", "recall_number": "D-0971-2018", "product_description": "Solco Healthcare US Valsartan, USP, 320 MG Tablets, 90-count bottle,Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd.  Xynqiao, Linhai, Zhejiang 317024, China  Distributed by:  Solco Healthcare US, LLC  Cranbury, NJ 08512 USA   NDC 43547-370-09", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180713", "center_classification_date": "20180720", "report_date": "20180801", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1141-2019", "product_description": "Dexamethasone 24 mg/mL Injection, 10 mL Vial,  Anderson Compounding Pharmacy, 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "3 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66403", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-66403-012", "product_description": "Amlodipine Besylate Tablets, USP 10 mg, packaged in a) 90-count bottles (NDC 0378-5210-77) and b) 500-count bottles (NDC 0378-5210-05), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.", "product_quantity": "101,450 bottles", "reason_for_recall": "CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.", "recall_initiation_date": "20130913", "center_classification_date": "20131104", "termination_date": "20150723", "report_date": "20131113", "code_info": "Lot #: a) 3038984, 3038985, 3038986, 3041484, 3041485; b) 3036828, 3036829, 3036830, 3036831, 3036832, 3038987, 3038988, 3038989, 3038990, 3041480, 3041481, 3041482, 3041483, 3044522, 3044525"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-578", "68001-579", "68001-580", "68001-581", "68001-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859871", "1719803", "1719862"], "spl_id": ["048557ea-f859-f0f2-e063-6294a90af5ab"], "spl_set_id": ["f2d14406-2ad4-4c5b-9c24-a026f27b415d"], "package_ndc": ["68001-579-59", "68001-579-48", "68001-580-41", "68001-581-41", "68001-581-48", "68001-581-82", "68001-578-59", "68001-578-48", "68001-582-41"], "is_original_packager": [true], "upc": ["0368001578592", "0368001581417", "0368001579599", "0368001582414"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96636", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0367-2025", "product_description": "Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-580-41.", "product_quantity": "2,110 vials", "reason_for_recall": "Lack of assurance of sterility. Bacterial contamination detected in some media fill units", "recall_initiation_date": "20250402", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "A240467B, EXP 07/31/2026"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206751"], "brand_name": ["METHYLPREDNISOLONE"], "generic_name": ["METHYLPREDNISOLONE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-916", "68382-917", "68382-918", "68382-919"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPREDNISOLONE"], "rxcui": ["197971", "197973", "259966", "328161", "762675"], "spl_id": ["e7c45905-daf8-4deb-bfa0-b2afe021a18a"], "spl_set_id": ["eaa9c932-c659-4ef6-bf5a-186545d87320"], "package_ndc": ["68382-916-01", "68382-916-05", "68382-916-34", "68382-917-11", "68382-917-01", "68382-917-05", "68382-917-30", "68382-917-77", "68382-918-18", "68382-918-01", "68382-918-05", "68382-918-30", "68382-918-77", "68382-919-11", "68382-919-01", "68382-919-05", "68382-919-30", "68382-919-77"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["X4W7ZR7023"]}, "product_type": "Drugs", "event_id": "82827", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1449-2019", "product_description": "MethylPREDNISolone Tablets, USP 4 mg per tablet, 21 Tablets dosepack, Rx Only,  Made in India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-916-34", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.", "recall_initiation_date": "20190506", "center_classification_date": "20190701", "termination_date": "20210916", "report_date": "20190626", "code_info": "Lots: M800150 Feb-20; M803930, M806006, M806007, M806008, M806009, M806010, M806011, EXP Mar-20; M807299, M807300, M807301, M807302, M807303, M807304, M807305, M807306, M807307, M807308, EXP May-20; M807779, M807780, M808194, M808195, M808196, M808197, M808198, EXP Jun-20; M811092, M811093, M811094, M811097, M811665, M811666, M811667, M813781, EXP Jul-20; M816286, M816288, M816289, M816290, M817612, EXP OCT-20;  M817613, M817614, M817615, M817616, M818315, EXP Nov-20; M820619, M820620, M820621, M901594, M901595, M901596, M901597, M903484, EXP Mar-21"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71553", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave", "address_2": "Suite A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1228-2015", "product_description": "Lisinopril tablets, USP 20mg packaged in 10-count blisters (NDC 68084-062-11); 10 blister packs per carton (NDC 68084-062-01); Rx only,  Manufactured by: Wockhardt Limited, Mumbai, India, Distributed by: Wockhardt, USA, LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA for American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217.", "product_quantity": "5,591 cartons", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150601", "center_classification_date": "20150708", "termination_date": "20170222", "report_date": "20150715", "code_info": "Lot#: 131934, Exp 09/30/2015"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1394-2022", "product_description": "VICKS VAPORUB 1.76 OZ SKU  919667   VICKS VAPOR RUB LAVENDER 1.76 OZ 999813   SWAN MEDICATED CHEST RUB 3.53 OZ SKU 920611 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 919667; 999813; 920611", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; MULTIVITAMIN/MULTIMINERAL, Tablet may be potentially mislabeled as     LISINOPRIL, Tablet, 2.5 mg, NDC 64679092701, Pedigree: AD25264_4, EXP: 5/3/2014.", "address_2": "", "product_quantity": "520 Tablets", "code_info": "MULTIVITAMIN/MULTIMINERAL, Tablet has the following code    Pedigree: AD23082_13, EXP: 11/1/2013.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MULTIVITAMIN/MULTIMINERAL, Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904549213", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-482-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Richland", "address_1": "199 Interstate Dr Ste N", "reason_for_recall": "CGMP Deviations; deficiencies at the manufacturer  may result in assay or content uniformity failures", "address_2": "", "product_quantity": "2,771 bottles", "code_info": "LOT # 28751601, exp 8/18", "center_classification_date": "20161129", "distribution_pattern": "Nationwide", "state": "MS", "product_description": "URAMIT MB URINARY ANTISEPTIC Capsules, Each capsule contains:  Methenamine 118 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue 10 mg, Hyoscyamine Sulfate, 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-300-10", "report_date": "20161207", "classification": "Class II", "openfda": {}, "recalling_firm": "Burel Pharmaceuticals Inc", "recall_number": "D-0157-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "75566", "termination_date": "20170814", "more_code_info": "", "recall_initiation_date": "20161024", "postal_code": "39218-9433", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Noblesville", "state": "IN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68191", "recalling_firm": "Pharmakon Pharmaceuticals", "address_1": "14450 Getz Rd", "address_2": "N/A", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States: TX, IL, MD, IN", "recall_number": "D-1565-2014", "product_description": "Midazolam HCl 2 mg/ml in 0.9% Sodium Chloride in 30 mL PVC Vial, Rx Only.  Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd., Noblesville IN  46060  NDC#: 45183-0234-68.", "product_quantity": "20 vials", "reason_for_recall": "Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.", "recall_initiation_date": "20140421", "center_classification_date": "20140826", "termination_date": "20141203", "report_date": "20140903", "code_info": "Lot #: E21294K3C Exp Date:  6/29/2014"}, {"status": "Ongoing", "city": "Chennai", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91621", "recalling_firm": "Global Pharma Healthcare Private Limited", "address_1": "A - 9 Sidco Pharmaceutical Complex", "address_2": "Thiruporur", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed to two distributors who further distributed Nationwide in the USA.", "recall_number": "D-0920-2023", "product_description": "Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle, Distributed by. EzriCare, LLC, Lakewood, NJ, NDC 79503-0101-15.", "product_quantity": "400,008 bottles total for all products", "reason_for_recall": "CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.", "recall_initiation_date": "20230130", "center_classification_date": "20230714", "report_date": "20230719", "code_info": "Lot #: PCMH009, PCMH010, PCMH011, PCMH012, PCMH013, PCMH014, PCMH015, PCMH016, exp. date Nov-2023; PCMI001, PCMI002, PCMI003, PCMI004, PCMI006, PCMI 07, PCMI 008, Exp. date AUG-2024; PCMJ003, PCMJ007, PCMJ016, Exp. date MAR-2025", "more_code_info": ""}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1040-2015", "product_description": "Azithromycin 100 mg Rectal Suppository, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1408-2022", "product_description": "TN DICKINSON WITCH HAZEL 16 FL OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU: 900911", "more_code_info": ""}, {"country": "United States", "city": "Schaumburg", "address_1": "1901 N Roselle Rd Ste 700", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out of specification results for an impurity.", "address_2": "", "product_quantity": "205,370 vials", "code_info": "Lot #: AJM601, Exp. Jul-2018; AJM701, AJM702, Exp. Dec-2018", "center_classification_date": "20180312", "distribution_pattern": "Nationwide in the USA.", "state": "IL", "product_description": "methylPREDNISolone Sodium Succinate for Injection, USP, 40 mg* per vial, Single-Dose Vial, Rx only, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-807-05.", "report_date": "20180321", "classification": "Class II", "openfda": {}, "recalling_firm": "Sagent Pharmaceuticals Inc", "recall_number": "D-0586-2018", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "79419", "termination_date": "20200415", "more_code_info": "", "recall_initiation_date": "20180305", "postal_code": "60195-3194", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA073509"], "brand_name": ["MORPHINE SULFATE"], "generic_name": ["MORPHINE SULFATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-3814", "0409-3815"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["EPIDURAL", "INTRATHECAL", "INTRAVENOUS"], "substance_name": ["MORPHINE SULFATE"], "rxcui": ["1728783", "1728800"], "spl_id": ["493a6182-2a85-4973-8a20-6bb2344d6452"], "spl_set_id": ["1d181906-f3ec-4222-1883-e61577a3122e"], "package_ndc": ["0409-3814-11", "0409-3814-12", "0409-3815-11", "0409-3815-12"], "is_original_packager": [true], "unii": ["X3P646A2J0"]}, "product_type": "Drugs", "event_id": "64720", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-308-2013", "product_description": "Preservative-Free MORPHINE Sulfate Injection, USP, 10 mg/10 mL (1 mg/mL) 10 mL vial, Rx only, HOSPIRA, INC, LAKE FOREST, IL 60045 USA NDC 0409-3815-12", "product_quantity": "26,100 vials", "reason_for_recall": "Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial", "recall_initiation_date": "20120828", "center_classification_date": "20130501", "termination_date": "20140918", "report_date": "20130508", "code_info": "Lot 15-065-DK, Exp 1SEP2013", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70118", "recalling_firm": "Walgreens Infusion Services", "address_1": "9030 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas, Florida, Virginia, Georgia, Louisiana, Mississippi", "recall_number": "D-0364-2015", "product_description": "Dobutamine various strengths in dextrose", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20141226", "center_classification_date": "20150116", "termination_date": "20150724", "report_date": "20150128", "code_info": "All products within expiry."}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-444-2015", "product_description": "Adventist Hinsdale Hospital (IL) Neonatal Starter: Troph 2% Dex10%, Trophamine 2% Dextrose 10%, Additives: heparin PF 0.5 unit(s)/ml, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "1 bag", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74765, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74765-0-1-R, Disp ID: 37-1124732"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0515-2018", "product_description": "Pentoxifylline USP for prescription compounding, packaged  in a) 25g (NDC 58597-8429-4); b) 100g (NDC 58597-8429-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "29550 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 092515-1, Exp. 5/31/2020; b) 092515-1, Exp. 5/31/2020."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units  may be potentially mislabeled as one of the following drugs:  SERTRALINE HCL, Tablet, 50 mg, NDC 16714061204, Pedigree: AD70585_7, EXP: 5/29/2014;  THYROID, Tablet, 60 mg, NDC 00456045901, Pedigree: W002848, EXP: 6/7/2014;  CHOLECALCIFEROL, Tablet, 2000 units, NDC 00904615760, Pedigree: W003744, EXP: 6/26/2014;  amLOD", "address_2": "", "product_quantity": "498 Capsules", "code_info": "PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units  has the following codes:   Pedigree: AD70585_10, EXP: 5/29/2014  Pedigree: W002850, EXP: 6/7/2014;  Pedigree: W003856, EXP: 6/26/2014  Pedigree: AD65457_4, EXP: 5/24/2014;  Pedigree: AD70655_1, EXP: 5/28/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units, Rx only, Distributed by: AidaPak Service, LLC,  NDC 00032122401.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-785-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New Albany", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "66233", "recalling_firm": "Tween Brands Inc", "address_1": "8323 Walton Pkwy", "address_2": "N/A", "postal_code": "43054-9522", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-358-2014", "product_description": "Lemon anti bac Justice, Ethyl Alcohol, Net Wt. 1 fl oz, Distr by Tween Brands New Albany, OH 43054 Toronto, ON L6T 3R5", "product_quantity": "27,590 bottles", "reason_for_recall": "Labeling: Label Error on Declared Strength; the label states that the product contains 62% ethyl alcohol, but the ethyl alcohol content is 20%.", "recall_initiation_date": "20130621", "center_classification_date": "20131213", "termination_date": "20140616", "report_date": "20131225", "code_info": "Style #190847 &190871"}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "2 Bags", "code_info": "Compounded on 05/29/2015, Discard After: 06/12/2015", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Vancomycin 750 mg/NS 100 ml accuflo, Packaged in 100 mL Bags, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1196-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Tulsa", "address_1": "12515 E 55th St Ste 100", "reason_for_recall": "Presence of Foreign Tablets/Capsules: One bottle of Percocet 10/325 mg was found to contain a tablet of Endocet 10/25 mg, the generic form.", "address_2": "", "product_quantity": "1 bottle", "code_info": "Lot # 6IHD, Exp 09/30/2013", "center_classification_date": "20130429", "distribution_pattern": "FL", "state": "OK", "product_description": "Percocet 10/325 mg tablets, 100-count tablets per bottle, Rx only, Dist. By: Physicians Total Care, Tulsa, OK  74146; Mfg. By: Novartis Consumer Health I, Lincoln, NE  68581; NDC 54868-4710-0, Barcode 47101006IHD.", "report_date": "20130508", "classification": "Class III", "openfda": {}, "recalling_firm": "Physicians Total Care, Inc.", "recall_number": "D-301-2013", "initial_firm_notification": "FAX", "product_type": "Drugs", "event_id": "65002", "termination_date": "20130517", "more_code_info": "", "recall_initiation_date": "20110523", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87076", "recalling_firm": "Complete Pharmacy and Medical Solutions, LLC.", "address_1": "5829 Nw 158th St", "address_2": "N/A", "postal_code": "33014-6721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0234-2021", "product_description": "HUMAN CHORIONIC GONADOTROPIN 11,000 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035", "product_quantity": "1182 vials", "reason_for_recall": "CGMP deviations: Lack of potency testing.", "recall_initiation_date": "20201120", "center_classification_date": "20210119", "termination_date": "20220928", "report_date": "20210127", "code_info": "Lot #: 40568 Use By Date: 01/30/2021", "more_code_info": ""}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "7 Bags", "code_info": "All product compounded between May 14, 2015 and May 27, 2015", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "TPN 3:1, 2000 mL Bags, Qty: 7, Base Formula Dextrose 70%, Travasol 10%, Intralipid 20%, Sterile Water; Electrolytes K Acetate, Na Acetate, Famotidine, Ca Gluconate, MgSO4, NaCl, Zinc Cl; Vitamins, trace elements and medications Salenium, Multi Vitamin, Vitamin K, Ascorbic Acid, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200 501-227-0900.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1154-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0107-2015", "product_description": "\"NB2014\" 30 mg/6 mg/300 mcg/0.3 mg/mL (phentolamine mesylate, papaverine, alprostadil, atropine) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "85 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07152014@52, Exp 9/30/2014; 07202014@7, Exp 10/18/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0747-2021", "product_description": "Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Manufactured by: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-5145-91", "product_quantity": "42,046 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: 313282585B, exp. date 11/2022"}, {"status": "Terminated", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84550", "recalling_firm": "Asclemed USA Inc. dba Enovachem Pharmaceuticals", "address_1": "379 Van Ness Ave Ste 1403", "address_2": "N/A", "postal_code": "90501-7211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Product was distributed to 6 physician's offices within the state of California.", "recall_number": "D-0650-2020", "product_description": "Estriol, USP, (Micronized), 0.06 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-36", "product_quantity": "8.52 gm", "reason_for_recall": "Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.", "recall_initiation_date": "20191209", "center_classification_date": "20200108", "termination_date": "20230809", "report_date": "20200115", "code_info": "Lot Code/Exp. Date: 11061901, 04011903, 04221904, 04241904,  06031902,  07301905, 09061903, EXP 12/31/2020"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "78 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  04212015@36, 7/20/2015; 03202015@56, 6/18/2015; 03182015@10, 6/16/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Methylcobalamin 10 mg/ml + 5 Methyl Tetrahydrofolate 4 mg/ml Injectable, Sterile-Multi-Dose Vial,Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1574-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-729-2015", "product_description": "Idoxuridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "362 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83206", "recalling_firm": "Amneal Pharmaceuticals, Inc.", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to three major distributors who may have further distributed the product nationwide.", "recall_number": "D-1516-2019", "product_description": "Methylergonovine Maleate USP 0.2 mg Tablets  a) 12 count (NDC 69238-1605-02) and b) 28 count bottles (NDC 69238-1605-08)", "product_quantity": "a) 2,256 bottles; b) 240 bottles", "reason_for_recall": "Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets", "recall_initiation_date": "20190718", "center_classification_date": "20190724", "termination_date": "20200422", "report_date": "20190731", "code_info": "a) Lot # BA10619A, b) Lot # BA10619B, exp. date 07/2020"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62924", "recalling_firm": "Physicians Total Care, Inc.", "address_1": "12515 E 55th St Ste 100", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "VA", "recall_number": "D-092-2013", "product_description": "Enjuvia (synthetic conjugated estrogens, B) tablets, 0.9mg, 30-count tablets per bottle, Rx only, Mfg. By: Duramed Pharmaceuticals, Pomona NY 10970; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK  74146; NDC 54868-6165-1.", "product_quantity": "5 Bottles", "reason_for_recall": "Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.", "recall_initiation_date": "20110408", "center_classification_date": "20121211", "termination_date": "20130222", "report_date": "20121219", "code_info": "Lot # 62QH, Exp 4/12"}, {"country": "United States", "city": "Huntersville", "address_1": "14235 Boren St", "reason_for_recall": "Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil", "address_2": "Apt 201", "product_quantity": "211 bottles; 339 boxes", "code_info": "a) RO846356 Exp. 8/28/2020; b) RO246852 Exp. 8/28/2020", "center_classification_date": "20170912", "distribution_pattern": "Nationwide", "state": "NC", "product_description": "Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY", "report_date": "20170920", "classification": "Class I", "openfda": {}, "recalling_firm": "Chiavna Saffron LLC", "recall_number": "D-1145-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77812", "termination_date": "20180327", "recall_initiation_date": "20170721", "postal_code": "28078-6516", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0034-2019", "product_description": "CVS Health, Saline Nasal Gel with Soothing Aloe, packaged as a) Baby Net Wt. 0.5 OZ (14.2 g) tube UPC 0 50428 58392 0 Product #282476; and b) Net Wt. 0.5 OZ tube (14.2 g) UPC 0 50428 31746 4 Product #896071; Distributed by CVS Pharmacy, Inc,. One CVS Drive, Woonsocket, RI 02895.", "product_quantity": "285,840 tubes", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86022", "recalling_firm": "4e Brands North America, Llc", "address_1": "17806 Ih-10 Ste 300", "address_2": "N/A", "postal_code": "78257", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0024-2021", "product_description": "blumen Clear ADVANCED HAND SANITIZER with 70% ALCOHOL, (ethyl alcohol 70% v/v), Packaged as a) 2 fl oz / 60 ml bottle, UPC 8 14266 02371 6 b) 7.5 fl oz / 221 ml bottle, UPC 8 14266 02362 4 c) 15.2 fl oz (450 ml) bottle, UPC 8 14266 02392 1, d) 17 fl oz / 503 ml bottle with blue cap or pump bottle, UPC 8 14266 02409 6, e) 18 fl oz / 532 ml bottle, UPC 8 14266 02391 4, f) 33.8 fl oz / 1 L straight or curved bottle, UPC 8 14266 02369 3  g) 70 fl oz / 2.07L bottle, UPC 8 14266 02367 9 h) 1.05 GAL / 4L bottle, UPC 8 14266 02368 6; Distributed in USA and Canada By: 4e Brands Northamerica LLC, 17806 IH-10W, Suite 300, San Antonio, Texas, 78257, Made in Mexico.", "product_quantity": "17,359,247 total bottles and pumps", "reason_for_recall": "CGMP Deviations: recalled because it was manufactured in the same facility as the product found to contain methanol which represents poor Current Good Manufacturing Practices.", "recall_initiation_date": "20200711", "center_classification_date": "20201007", "termination_date": "20240226", "report_date": "20201007", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "61233", "recalling_firm": "Physicians Total Care, Inc", "address_1": "12515 E 55th St Ste 100", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "FL", "recall_number": "D-1386-2012", "product_description": "Morphine Sulfate Immediate Release tablet, 30 mg/120 tablet bottles, Rx only,   Physician Total Care, Inc, Tulsa, OK 74146-6234, NDC 54868-4973-00", "product_quantity": "600 tablets (5 containers of 120 tablets each)", "reason_for_recall": "Labeling: Label mix-up; Bottles labeled to contain Morphine Sulfate IR may contain Morphine Sulfate ER and vice-versa.", "recall_initiation_date": "20101110", "center_classification_date": "20120618", "termination_date": "20120724", "report_date": "20120627", "code_info": "PTC Drug Number: 4973.  PTC Batch Number: 65J2.  Batch Date: 10/13/2010.  Expiration Date: 06/30/2012.  NDC: 54868-4973-00"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019627"], "brand_name": ["DIPRIVAN"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-269"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808219", "1808222", "1808223", "1808224", "1808225", "1808234", "1808235"], "spl_id": ["fcc6b79c-5aa5-4c9f-8f58-fb0a1eeaceec"], "spl_set_id": ["ee0c3437-614d-4631-a061-257f5f60c70b"], "package_ndc": ["63323-269-30", "63323-269-50", "63323-269-35", "63323-269-65", "63323-269-22", "63323-269-29", "63323-269-01", "63323-269-10"], "is_original_packager": [true], "upc": ["0363323269302", "0363323269357", "0363323269012", "0363323269227"], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1116-2022", "product_description": "Diprivan (Propofol) Emulsion, 200 mg per 20 mL (10mg/mL), 20 mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-29", "product_quantity": "46 cartons", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65125", "recalling_firm": "THE COMPOUNDING SHOP, INC.", "address_1": "4000 Park St N", "address_2": "N/A", "postal_code": "33709-4034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, California, Minnesota, and Maine", "recall_number": "D-555-2013", "product_description": "Dexamethasone 10 mg/mL Injectable, 2 mL vial, compounded by The Compounding Shop, St. Petersburg, FL", "product_quantity": "41 vials of  2mL", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130502", "center_classification_date": "20130604", "termination_date": "20240930", "report_date": "20130612", "code_info": "All Lots"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0978-2023", "product_description": "heparin 4000 units/1000mL added to 0.9% sodium chloride, 4 units/mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-7022-1", "product_quantity": "11,824 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-243555, 36-243556, Exp. 7/10/2023; 36-245117, 36-245118, 36-245119, 36-245120, Exp. 7/12/2023; 36-246163, 36-246164, Exp. 7/14/2023; 36-247010, Exp. 7/18/2023; 36-248226, 36-248229, 36-248232, 36-248248, Exp. 7/24/2023; 36-249829, 36-249830, 36-249831, 36-249832, Exp. 8/1/2023; 36-250047, 36-250048, 36-250049, 36-250050, Exp. 8/2/2023; 36-250289, 36-250290, 36-250291, 36-250293, Exp. 8/3/2023; 36-251057, 36-251058, 36-251060, Exp. 8/4/2023; 36-251385, 36-251386, 36-251387, 36-251388, Exp. 8/7/2023; 36-251448, 36-251449, 36-251450, Exp. 8/8/2023; 36-252462, Exp. 8/14/2023; 36-254679, 36-254681, Exp. 8/16/2023; 36-255116, 36-255117, 36-255118, Exp. 8/17/2023; 36-255488, Exp. 8/18/2023."}, {"status": "Ongoing", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209713"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-965", "68180-966", "68180-967", "68180-968", "68180-969", "68180-970", "68180-971", "68180-972", "68180-973", "68180-974", "68180-975", "68180-976"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["94052e3d-58b2-4f4b-8223-a47281c1a592"], "spl_set_id": ["18717e58-89fb-4e2f-93b6-d6ac3e988d37"], "package_ndc": ["68180-965-03", "68180-965-02", "68180-965-09", "68180-965-01", "68180-966-03", "68180-966-02", "68180-966-09", "68180-966-01", "68180-967-03", "68180-967-02", "68180-967-09", "68180-967-01", "68180-968-09", "68180-968-02", "68180-968-01", "68180-968-03", "68180-969-01", "68180-969-02", "68180-969-03", "68180-969-09", "68180-970-01", "68180-970-02", "68180-970-03", "68180-970-09", "68180-971-01", "68180-971-02", "68180-971-03", "68180-971-09", "68180-972-01", "68180-972-02", "68180-972-03", "68180-972-09", "68180-973-01", "68180-973-02", "68180-973-03", "68180-973-09", "68180-974-01", "68180-974-02", "68180-974-03", "68180-974-09", "68180-975-03", "68180-975-02", "68180-975-01", "68180-975-09", "68180-976-01", "68180-976-02", "68180-976-03", "68180-976-09"], "is_original_packager": [true], "upc": ["0368180973010", "0368180971016", "0368180972013", "0368180969013", "0368180966012", "0368180970019", "0368180968016", "0368180967019", "0368180965015", "0368180976011", "0368180974017"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95892", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "One US distributor in Ohio.", "recall_number": "D-0167-2025", "product_description": "Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03", "product_quantity": "480 1000-count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.", "recall_initiation_date": "20241220", "center_classification_date": "20241230", "report_date": "20250108", "code_info": "Lot# LA01276, Exp Date: 07/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022231"], "brand_name": ["TERLIVAZ"], "generic_name": ["TERLIPRESSIN"], "manufacturer_name": ["Mallinckrodt Hospital Products Inc."], "product_ndc": ["43825-200"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TERLIPRESSIN"], "rxcui": ["2612431", "2612436"], "spl_id": ["1d0832a2-debc-40bf-8bbe-59383d0bd3c6"], "spl_set_id": ["3a35b86c-f451-4fac-8499-43019e4da354"], "package_ndc": ["43825-200-01"], "is_original_packager": [true], "nui": ["N0000194045", "N0000194046"], "pharm_class_epc": ["Vasopressin Receptor Agonist [EPC]"], "pharm_class_moa": ["Vasopressin Receptor Agonists [MoA]"], "unii": ["7Z5X49W53P"]}, "product_type": "Drugs", "event_id": "93945", "recalling_firm": "Mallinckrodt Hospital Products Inc.", "address_1": "440 Us Highway 22", "address_2": "Ste 302", "postal_code": "08807-2477", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0341-2024", "product_description": "Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01", "product_quantity": "421 vials involved in this recall (2,448 vials distributed)", "reason_for_recall": "cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.", "recall_initiation_date": "20240206", "center_classification_date": "20240221", "report_date": "20240228", "code_info": "Lot #: 22TRP01-F2, Exp 6/30/2024"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "42 units", "code_info": "Rx # 29087 Exp. 5/28/2014", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Meropenem 1 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29087, Discard After 05/28/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1461-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78123", "recalling_firm": "Medisca, Inc.", "address_1": "661 State Route 3 Unit C", "address_2": "N/A", "postal_code": "12901-6531", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1174-2017", "product_description": "Aminocaproic Acid, USP (6-Aminohexanoic Acid) active pharmaceutical ingredient, packaged in a) 100 g jar (NDC 38779-0989-05, b) 1 kg jar (NDC 38779-0989-09), and 25 kg drum (NDC 38779-0989-07), Rx only, Packed by Medisca Inc., Plattsburgh, NY  12901, CAS: 60-32-1.  38779-0989-05; jar, 300 ml, white HDPE  38779-0989-07; drum, 15 gallon, Fiber  38779-0989-09; 2.8L, white, HDPE", "product_quantity": "34,600 g", "reason_for_recall": "CGMP Deviations: Product manufactured for \u001cIndustrial Use but was labeled and distributed for Pharmacy Compounding Use.", "recall_initiation_date": "20170914", "center_classification_date": "20170920", "termination_date": "20181204", "report_date": "20170927", "code_info": "Lots# 143595/A,143595/B,143595/D, Exp 02/28/20", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Incorrect expiration date.", "address_2": "", "product_quantity": "100 syringes", "code_info": "Lot#: 12/31/18 0555 21072S, Exp 3/31/2019", "center_classification_date": "20190215", "distribution_pattern": "PA", "state": "TX", "product_description": "Fentanyl in 0.9% Sodium Chloride QS 0.5 mL, 5 mcg/0.5 mL with up to 0.1 mL of overfill Injectable Solution, Sterile single use syringe, Rx only, Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404, NDC 42852-210-72", "report_date": "20190227", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0496-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "82130", "termination_date": "20191030", "more_code_info": "", "recall_initiation_date": "20190206", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67881", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave", "address_2": "Suite A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1189-2014", "product_description": "HydrOXYzine HCl Tablets, USP  50 mg, 100 Tablet Blister, Rx only Mfd by: KVK-TECH, INC. Newtown, PA 18940, NDC 68084-255-01", "product_quantity": "8,570 blister packs", "reason_for_recall": "Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an  unapproved source.", "recall_initiation_date": "20140131", "center_classification_date": "20140403", "termination_date": "20150401", "report_date": "20140409", "code_info": "Lot 120757, Exp. 02/14; Lot 121104, Exp 03/14; Lot 122055, Exp 05/14; Lot  123038, Exp  07/14;  Lot 125115, Exp 11/14"}, {"status": "Terminated", "city": "Thousand Oaks", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125320"], "brand_name": ["PROLIA"], "generic_name": ["DENOSUMAB"], "manufacturer_name": ["Amgen, Inc"], "product_ndc": ["55513-710"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["DENOSUMAB"], "rxcui": ["993452", "993456"], "spl_id": ["f5a330b4-e272-4aa1-9fce-afdfce5543aa"], "spl_set_id": ["49e5afe9-a0c7-40c4-af9f-f287a80c5c88"], "package_ndc": ["55513-710-01", "55513-710-21"], "is_original_packager": [true], "nui": ["N0000187055", "N0000187054"], "pharm_class_epc": ["RANK Ligand Inhibitor [EPC]"], "pharm_class_moa": ["RANK Ligand Blocking Activity [MoA]"], "unii": ["4EQZ6YO2HI"], "upc": ["355513710015"]}, "product_type": "Drugs", "event_id": "66318", "recalling_firm": "Amgen, Inc.", "address_1": "1 Amgen Center Dr", "address_2": "N/A", "postal_code": "91320-1730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico, Canada, Mexico, and clinical distribution in Europe.", "recall_number": "D-66318-001", "product_description": "Prolia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syringe per carton, Rx only, Manufactured by: Amgen Manufacturing Ltd., a subsidiary of Amgen Inc., Thousand Oaks, CA  91320-1799,NDC 55513-710-01, UPC 3 55513 71001 5.", "product_quantity": "4,163 prefilled syringes", "reason_for_recall": "Presence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination.", "recall_initiation_date": "20130917", "center_classification_date": "20131104", "termination_date": "20140602", "report_date": "20131113", "code_info": "Lot #: 1037592, Exp 07/15"}, {"country": "United States", "city": "Salt Lake City", "address_1": "575/577/579 Chipeta Way", "reason_for_recall": "Subpotent Drug: Drug potency was compromised during shipment.", "address_2": "", "product_quantity": "38,227 Clamshells", "code_info": "Lot #: 514656; Expiry: 03/14", "center_classification_date": "20140225", "distribution_pattern": "Distributed nationwide to physicians as samples.  No military/ govt/ VA or foreign consignees.", "state": "UT", "product_description": "Gelnique (oxybutynin chloride) Gel 10%, 100 mg in 1 g sachet, for topical use only.  Physician sample in clamshell container with seven heat-sealed sachets.  Rx Only.  Watson Pharmaceuticals Inc, Corona, CA, 92890.  NDC: 52544-084-77.", "report_date": "20140305", "classification": "Class III", "openfda": {}, "recalling_firm": "Actavis", "recall_number": "D-1088-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67457", "termination_date": "20140905", "more_code_info": "", "recall_initiation_date": "20140207", "postal_code": "84108-1222", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0404-2024", "product_description": "HYDROmorphone HCl 20 mg/100mL in 0.9% Sodium Chloride Injection, 100 mL Grey CADD Cassette (20 mg/100 mL), CII, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0300-63, Bar Code 70004030063", "product_quantity": "256 cassettes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223049529, Exp 01/03/24", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["SIGNATURE CARE NASAL DECONGESTANT"], "generic_name": ["OXYMETAZOLINE HCL"], "manufacturer_name": ["Safeway"], "product_ndc": ["21130-801"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["5e43b82c-f0c4-4389-8f86-2d8c62da7231"], "spl_set_id": ["23f0a5b3-59ae-4eb3-9b7d-e6a492060337"], "package_ndc": ["21130-801-10"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0622-2022", "product_description": "No Drip Nasal Decongestant, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle, DISTRIBUTED BY: BETTER LIVING BRANDS LLC, P.O. BOX 99, PLEASANTON, CA 94566-0009. NDC 21130-801-10", "product_quantity": "11,088 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0964, Exp 01/31/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M028"], "brand_name": ["KINGSKIN"], "generic_name": ["SALICYLIC ACID"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-409"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["SALICYLIC ACID"], "rxcui": ["312881"], "spl_id": ["30de65a3-4991-e4d0-e063-6294a90a728c"], "spl_set_id": ["09974c86-6fba-3f20-e063-6294a90abd89"], "package_ndc": ["55758-409-15"], "is_original_packager": [true], "unii": ["O414PZ4LPZ"]}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0381-2025", "product_description": "Kingskin, Elimina Las Verrugas, For the removal of common warts, 0.50 oz fl (15 mL), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-409-15", "product_quantity": "20,048 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot, expiry: KSE-01, EXP: OCT 26; KSE-02, EXP: FEB 27"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76982", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0669-2017", "product_description": "BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 100 mg, packaged in a) 60-count bottles (NDC 59746-315-60) and b) 100-count bottles (NDC 59746-315-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD  21801, USA.", "product_quantity": "20,882 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.", "recall_initiation_date": "20160408", "center_classification_date": "20170413", "termination_date": "20170417", "report_date": "20170419", "code_info": "Lot #s: a) BU15001B, BU15003D, Exp 12/16; b) BU15002A, Exp 12/16", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0440-2018", "product_description": "Potassium Chloride in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Chatsworth", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "82758", "recalling_firm": "D.B.P. Distribution", "address_1": "23550 Ehlers Dr", "address_2": "", "postal_code": "91311-6310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide.", "recall_number": "D-1292-2019", "product_description": "Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000  UPC 86077000020", "product_quantity": "unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA: undeclared  sildenafil and tadalafil.", "recall_initiation_date": "20190423", "center_classification_date": "20190522", "termination_date": "20230307", "report_date": "20190522", "code_info": "Expiration 12/29/2020", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #: T0389114", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ACETIC ACID, IRRIGATION  3% SOLUTION 500 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1448-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-065-2014", "product_description": "Calcium Gluconate 10% 50ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "25 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75650", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0461-2017", "product_description": "Nystatin Oral Suspension, USP 500,000 Units/5 mL, a). 50 unit dose cups of 5 mL per case (NDC No. 66689-037-50), b). 100 unit dose cups of 5 mL per case (NDC 66689-037-99), Rx only, Manufactured by VistaPharm, Largo, FL 33771.", "product_quantity": "55,191 unit dose cups", "reason_for_recall": "CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.", "recall_initiation_date": "20170118", "center_classification_date": "20170202", "termination_date": "20210826", "report_date": "20170208", "code_info": "a). Lot No. 428900, 425600 (Exp. 05/17); 421200 (Exp. 04/17), 413600 (Exp. 02/17), 411500 (Exp. 01/17), 417200 (Exp. 03/17)   b). Lot No. 429300 (Exp. 06/17) ,426500 (Exp. 05/17), 420600 (Exp. 03/17), 417000 (Exp.03/17), 412900 (Exp. 01/17), 409900 (Exp. 01/17)", "more_code_info": ""}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1083", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Cefazolin 2GM added to 100 mL 0.9% Sodium Chloride bag Rx Only,Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0216-48", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1279-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Broomfield", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64118", "recalling_firm": "Sandoz Incorporated", "address_1": "2555 W Midway Blvd", "address_2": "N/A", "postal_code": "80020-1632", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-152-2013", "product_description": "Syeda (drospirenone and ethinyl estradiol), 3 mg/0.03 mg, 3 x 28 tablet blistercards, combination oral contraceptive tablet, Manufactured by Laboratorios Leon Farma S.A., Spain for Sandoz Inc., Princeton, NJ", "product_quantity": "17,188 cartons containing 3 cards each.", "reason_for_recall": "Tablet/Capsule Imprinted with Wrong ID; a portion of the tablets could contain the incorrect debossing on one side of the tablet U2 instead of U3.", "recall_initiation_date": "20130122", "center_classification_date": "20130206", "termination_date": "20130507", "report_date": "20130213", "code_info": "LF01215A, Exp 02/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0130-2016", "product_description": "TESTOSTERONE, Pellet, 116 mg,  Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "1 pellet", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t04092015@12"}, {"status": "Terminated", "city": "Bellmawr", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72304", "recalling_firm": "C. O. Truxton", "address_1": "136 Harding Ave", "address_2": "N/A", "postal_code": "08031-2412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0164-2016", "product_description": "Doxycycline Hyclate Tablets, USP, 100 mg, 500-count bottle, Rx only, Distributed by: Truxton Inc. Bellmawr, NJ 08031, Manufactured for: Blu Caribe Dorado, PR 00646 USA, NDC 0463-6000-50 (top panel) NDC 24658-312-05 (side panel)", "product_quantity": "287 bottles", "reason_for_recall": "Labeling: Wrong Bar Code", "recall_initiation_date": "20150824", "center_classification_date": "20151110", "termination_date": "20160725", "report_date": "20151118", "code_info": "Lot # 13D0011FP8, Exp 09/15"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0810-2023", "product_description": "Hydrocortisone and Acetic Acid Otic Solution, USP, 10 mL bottles, Rx Only, Distributed by: Akorn, Inc., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0160-2015", "product_description": "Tri-mix ST9-E, 30 mg/4 mg/150 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "150 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 03142014@14, Exp 9/10/2014; 08062014@49, Exp 1/20/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85212", "recalling_firm": "PharMEDium Services, LLC", "address_1": "36 Stults Rd", "address_2": "N/A", "postal_code": "08810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1081-2020", "product_description": "ePHEDrine Sulfate, 5 mg per mL, 50 mg per 10 mL,  In 0.9% Sodium Chloride 10 mL syringe, For IV Use Preservative Free PharMEDium 913 N. Davis Ave. Cleveland, MS NDC 71030-003-12", "product_quantity": "1075 units", "reason_for_recall": "Firm is recalling 46 lots of various products because of a lack of sterility assurance.", "recall_initiation_date": "20200316", "center_classification_date": "20200406", "termination_date": "20250214", "report_date": "20200415", "code_info": "193500004D  3/16/2020  193510006D   3/17/2020  193530011D  3/19/2020  193570003D 3/23/2020"}, {"status": "Ongoing", "city": "Panchmahal", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA215076"], "brand_name": ["DOXEPIN HYDROCHLORIDE"], "generic_name": ["DOXEPIN HYDROCHLORIDE"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-637", "62332-638", "62332-645", "62332-639", "62332-640"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXEPIN HYDROCHLORIDE"], "rxcui": ["1000048", "1000058", "1000070", "1000076", "1000097"], "spl_id": ["c3977b05-a9fc-4cc4-adfc-731abe6613dd"], "spl_set_id": ["4920401a-cde5-404b-82aa-c3c0e8911065"], "package_ndc": ["62332-637-31", "62332-637-91", "62332-638-31", "62332-638-91", "62332-645-31", "62332-645-91", "62332-639-31", "62332-639-91", "62332-640-31", "62332-640-91", "2305015142"], "is_original_packager": [true], "upc": ["0362332645312"], "unii": ["3U9A0FE9N5"]}, "product_type": "Drugs", "event_id": "97323", "recalling_firm": "Alembic Pharmaceuticals Limited", "address_1": "Formulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0566-2025", "product_description": "Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31", "product_quantity": "9,492 bottles", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.", "recall_initiation_date": "20250725", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "Lot: 2305015142, Exp. Date: 9/30/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0108-2023", "product_description": "QuadMix Super 002 (PGE1/Papaverine HCl/Phentolamine Mesylate/Atropine) 40mcg/30mg/4mg/0.4mg/mL INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "6 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 12062022@1, Exp 1/20/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90599", "recalling_firm": "Vi-Jon, LLC", "address_1": "1 Swan Dr", "address_2": "", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA as well as Canada and Panama.", "recall_number": "D-1504-2022", "product_description": "meijer, magnesium citrate Saline Laxative, Oral Solution, (1.745 g/fl oz), Lemon Flavor, 10 FL OZ (296 mL), Dist. By Meijer Distribution, Inc. Grand Rapids, MI 49544; NDC 41250-708-38 UPC 7 13733 45945 7", "product_quantity": "L 22,965,330 C 10,070,526 G 8,064,834", "reason_for_recall": "Microbial contamination of non-sterile products.", "recall_initiation_date": "20220715", "center_classification_date": "20220909", "termination_date": "20240509", "report_date": "20220921", "code_info": "Lot# 0557622, EXP 1/12/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0581-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Allergy & Hay Fever Reliever, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955504320, NDC 57955-5043-2", "product_quantity": "11321 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 051016D Exp. 05/19; 052517D Exp. 05/20; 071316J Exp. 07/19; 082015D Exp. 0818; 041618A Exp. 04/20; 101017F Exp. 10/19"}, {"status": "Terminated", "city": "Lindon", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80119", "recalling_firm": "MBi Distributing Inc. dba MBi Nutraceuticals", "address_1": "211 N 1800 W", "address_2": "N/A", "postal_code": "84042-1627", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0869-2018", "product_description": "Intestinal Colic Drops, Homeopathic Drops for Temporary Relief of Flatulent Colic, 1 ounce amber glass bottle with glass dropper, liquid, Meteorism, and Porphyrinuria. MBi Nutraceuticals Lindon, UT 84042", "product_quantity": "78 bottles", "reason_for_recall": "Lack of Processing Controls: Firm is voluntarily recalling all lots of homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir, within expiry, due to lack of adequate controls during manufacturing.", "recall_initiation_date": "20180515", "center_classification_date": "20180614", "termination_date": "20200123", "report_date": "20180620", "code_info": "Lot: 8040802, EXP 04/2021."}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0924-2022", "product_description": "Dexpanthenol 250 mg/mL Multi-Dose 30 mL Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0070-30", "product_quantity": "1296 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: L24016 BUD: 6/16/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0251-2016", "product_description": "ePHEDrine Sulfate PF (50 mg/10 mL), 10 mL Single-Use Syringe, For IV or IM Use  Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3084-07", "product_quantity": "12,191 syringes", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20151706@45 BUD: 12/14/2015; 20151707@16 BUD: 1/13/2016; 20150904@17 BUD: 10/6/2015; 20151703@19 BUD: 9/13/2015; 20153003@7 BUD: 9/26/2015; 20153006@42 BUD: 12/27/2015"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0987-2023", "product_description": "NORepinephrine 4 mg/250 mL added to 0.9% sodium chloride 16 mcg/mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043,  NDC: 72196-8097-1", "product_quantity": "I,I87 bags.", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-241043, 36-241044, 36-241045, 36-241046, Exp. 7/18/2023."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA204570"], "brand_name": ["TESTOSTERONE"], "generic_name": ["TESTOSTERONE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-2924", "0591-2925", "0591-2926"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["TESTOSTERONE"], "rxcui": ["1597076", "1597120", "1597126"], "spl_id": ["fd8212ce-f9da-496c-81e5-db122080bac8"], "spl_set_id": ["4f3c2c0a-7dab-4b50-9cae-869c3c2a8498"], "package_ndc": ["0591-2924-18", "0591-2925-32", "0591-2925-30", "0591-2926-25", "0591-2926-30"], "is_original_packager": [true], "nui": ["N0000175824", "N0000000146", "M0001109"], "pharm_class_epc": ["Androgen [EPC]"], "pharm_class_moa": ["Androgen Receptor Agonists [MoA]"], "pharm_class_cs": ["Androstanes [CS]"], "unii": ["3XMK78S47O"]}, "product_type": "Drugs", "event_id": "93409", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "USA nationwide", "recall_number": "D-0127-2024", "product_description": "Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30", "product_quantity": "", "reason_for_recall": "OOS for viscosity", "recall_initiation_date": "20231110", "center_classification_date": "20231129", "termination_date": "20240603", "report_date": "20231206", "code_info": "Lot #: 100029472, Exp. 2/29/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0208-2023", "product_description": "FLURBIPROFEN -CORN OIL- 0.04% (3ML DROPTAINER) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221116@36", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA208234"], "brand_name": ["DESFLURANE"], "generic_name": ["DESFLURANE"], "manufacturer_name": ["Sandoz Inc."], "product_ndc": ["0781-6172"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["DESFLURANE"], "rxcui": ["562366"], "spl_id": ["ecf9968e-58b0-4792-e053-2995a90aef25"], "spl_set_id": ["21ba0e18-3dbc-4feb-a3a4-f6470c00910a"], "package_ndc": ["0781-6172-22", "0781-6172-86"], "is_original_packager": [true], "upc": ["0307816172229"], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["CRS35BZ94Q"]}, "product_type": "Drugs", "event_id": "86568", "recalling_firm": "eVenus Pharmaceutical Laboratories", "address_1": "506 Carnegie Ctr", "address_2": "Suite 100", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CO only", "recall_number": "D-0042-2021", "product_description": "Desflurane, USP Liquid for Inhalation, 240 mL, Rx Only,  Manufactured by: Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, 200245, China for Sandoz Inc. Princeton, NJ 08540, NDC 0781-6172-22", "product_quantity": "9210 units", "reason_for_recall": "DEFECTIVE CONTAINER: Desflurane Liquid for Inhalation 240 mL may be leaking.", "recall_initiation_date": "20201006", "center_classification_date": "20201020", "termination_date": "20220519", "report_date": "20201028", "code_info": "Lot #: 20011831, Exp. Date 12/2021; 20041431, Exp. Date 03/2022"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77374", "recalling_firm": "Pharmedium Services Llc", "address_1": "150 N Field Dr", "address_2": "N/A", "postal_code": "60045-4847", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0935-2017", "product_description": "Bupivacaine HCl 0.25% 270 mL Total Volume in an ON-Q Pump in 0.9% Sodium Chloride Injection in 270 mL, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-044-57", "product_quantity": "2 I.V. pumps", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20170215", "center_classification_date": "20170702", "termination_date": "20200113", "report_date": "20170712", "code_info": "Lot: 170320107s; Exp. 01/01/1900"}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1427-2020", "product_description": "Progesterone (Modified Release) 150 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "600 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "02-05-2020:07@6, BUD 8/3/2020"}, {"status": "Terminated", "city": "Toronto", "state": "N/A", "country": "Canada", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69546", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0244-2015", "product_description": "Candesartan Cilexetil Tablets, 32 mg, a) 30-count bottle (NDC 60505-3621-3) b) 90-count bottles (NDC 60505-3621-9) Rx Only, Manufactured by Apotex Research Pvt. Ltd., Bangalore- 560 099, India, Manufactured for Apotex Corp., Weston, FL 33326", "product_quantity": "22,710 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.", "recall_initiation_date": "20141016", "center_classification_date": "20141106", "termination_date": "20160930", "report_date": "20141112", "code_info": "Lot #: a) KR3955; Exp. 10/15, KV0430, Exp. 11/15   Lot #: b) KT6063;  Exp. 10/15"}, {"status": "Terminated", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66188", "recalling_firm": "Wellness Pharmacy, Inc.", "address_1": "3401 Independence Drive Suite 231", "address_2": "N/A", "postal_code": "35209-8326", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1031-2013", "product_description": "Magnesium Sulfate Hepta 50% PF, Single Use Vial, a) 2 mL, b) 10 mL, WELLNESS PHARMACY, 1-800-227-2627", "product_quantity": "590 Vials", "reason_for_recall": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.", "recall_initiation_date": "20130823", "center_classification_date": "20130912", "termination_date": "20140603", "report_date": "20130918", "code_info": "Lot# 130613@38, Use By:  12/10/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0291-2020", "product_description": "S-TESTOSTERONE PROPIONATE 100MG/ML MDV IN SESAME OIL, Rx Only, 5ML glass vial, Red Mountain Compounding Rx.", "product_quantity": "2x10 ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:S04222019DH@03 Exp 10/22/2019, S06162019DH@05, Exp 12/16/2019"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090174"], "brand_name": ["VENLAFAXINE HYDROCHLORIDE"], "generic_name": ["VENLAFAXINE HYDROCHLORIDE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-034", "68382-035", "68382-036"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VENLAFAXINE HYDROCHLORIDE"], "rxcui": ["313581", "313583", "313585"], "spl_id": ["8c02c121-fe14-45f5-b2bc-b09fd377531f"], "spl_set_id": ["5351fe67-17d9-42ec-9e8b-6585fdb9e29e"], "package_ndc": ["68382-034-06", "68382-034-16", "68382-034-10", "68382-035-06", "68382-035-16", "68382-035-10", "68382-036-06", "68382-036-16", "68382-036-10"], "is_original_packager": [true], "upc": ["0368382034106", "0368382035103", "0368382036100"], "unii": ["7D7RX5A8MO"]}, "product_type": "Drugs", "event_id": "74753", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1461-2016", "product_description": "Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by :  Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.", "product_quantity": "N/A", "reason_for_recall": "Failed Dissolution Specifications: out of specification dissolution results in retained samples", "recall_initiation_date": "20160719", "center_classification_date": "20160818", "termination_date": "20200921", "report_date": "20160824", "code_info": "Lot #: a) MS1217,  MS1218 , Exp.12/2017.  Lot #: b) MS1215, Exp.12/2017  Lot #: c) MR11150, MR11151, MR11854, Exp. 10/2017; MR11798, MR11799, MS1214, Exp.11/2017"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0848-2023", "product_description": "Sulfamethoxazole & Trimethoprim Oral Suspension USP, 200mg/40mg per 5mL, 473 mL bottles, Cherry Flavor, Rx only, Manufactured by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"country": "United States", "city": "New London", "address_1": "170 Broad St", "reason_for_recall": "Failed Stability Specifications: Unable to meet shelf life expiry.", "address_2": "", "product_quantity": "105,744 tubes", "code_info": "Lot # 10301, Exp 05/14    Lot # 10302, Exp 05/14", "center_classification_date": "20130614", "distribution_pattern": "PA, GA, WA, CA", "state": "CT", "product_description": "Dr. Sheffield's Triple Antibiotic Ointment Bacitracin 400 units, Neomycin Sulfate 3.5mg, Polymyxin-B Sulfate 5,000 units, First Aid Antibiotic Ointment, Net Wt. 0.33oz (9g)", "report_date": "20130626", "classification": "Class III", "openfda": {}, "recalling_firm": "Faria Limited LLC dba Sheffield Pharmaceuticals", "recall_number": "D-604-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65349", "termination_date": "20140328", "more_code_info": "", "recall_initiation_date": "20130528", "postal_code": "06320-5313", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA214554"], "brand_name": ["FOSFOMYCIN TROMETHAMINE"], "generic_name": ["FOSFOMYCIN TROMETHAMINE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-749"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FOSFOMYCIN TROMETHAMINE"], "rxcui": ["808917"], "spl_id": ["f6a079bc-179c-46e4-9077-96168cdd1cf9"], "spl_set_id": ["48e352bc-52ea-4778-905a-60ef38a5c18a"], "package_ndc": ["67877-749-57"], "is_original_packager": [true], "unii": ["7FXW6U30GY"]}, "product_type": "Drugs", "event_id": "92706", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The recall product was distributed nationwide.", "recall_number": "D-1145-2023", "product_description": "Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC# 67877-749-57", "product_quantity": "99,516 sachets", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.", "recall_initiation_date": "20230718", "center_classification_date": "20230906", "report_date": "20230913", "code_info": "Lot #22121970, 22122158, 22121971, 22122189, 22122190, 22122277, 22122278, Exp June 2024; 22122521, 22122522, 22122523, Exp July 2024; 22123328, 22123329, 22123330, Exp September 2024."}, {"status": "Terminated", "city": "Detroit", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68209", "recalling_firm": "Caraco Pharmaceutical Laboratories, Ltd.", "address_1": "1150 Elijah McCoy Dr", "address_2": "N/A", "postal_code": "48202-3344", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "OH", "recall_number": "D-1407-2014", "product_description": "Gemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Single Use Vial, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd, Gujarat, India, NDC 47335-154-40", "product_quantity": "200 vials", "reason_for_recall": "Lack of Assurance of Sterility: A particle excursion for a different batch of the same product may lead to a lack of sterility assurance.", "recall_initiation_date": "20140409", "center_classification_date": "20140620", "termination_date": "20140929", "report_date": "20140702", "code_info": "JKM7188A"}]